newsfilter
← Latest News
GlobeNewswire·

Sunesis Pharmaceuticals Announces Clinical Update on Vecabrutinib Program

SOUTH SAN FRANCISCO, Calif., June 23, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that the Company will not advance its non-covalent BTK inhibitor...